Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Israeli start-up Endospan, specializing in endovascular repair technologies for aortic arch disease, has appointed former Endologix executive Kevin Mayberry as CEO.
Eric Compton, a rising industry executive is set to take the helm at the hemostatic device-maker Z-Medica. He follows in the footsteps of President and CEO Stephen Fanning.
Emerging drug delivery firm Pertinax has hired a new business development manager to lead commercialization of its technology in the wound care market.
Siemens Healthineers has tapped the former president of Abbott's vascular division as its new head of laboratory diagnostics. The new business president succeeds Franz Walt, who served in the role from 2014-2017.
Neuromod Names New CSO To Complete TENT-A Tinnitus Trial And Advance Noninvasive Neuromodulation Platform
Neuromod, a Dublin, Ireland-based emerging medical technology firm focusing on noninvasive neuromodulation technologies, has named neurostimulation expert Hubert Lim as its new CSO to conclude the company's TENT-A tinnitus trial in Ireland and Germany.
Clinical genomics business Congenica has found a new CEO to lead the company's international expansion.
Vitor Rocha, head of Philips' global ultrasound business, has taken over from Brent Shafer as CEO of Philips North America.
Illumina spin-out Grail has started the new year with a new CEO at the helm. Jennifer Cook joins the firm from Swiss pharma and diagnostics giant Roche.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.